Global Medical Imaging Reagents Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Medical Imaging Reagents Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Medical imaging reagent is defined as substance administered to patients before medical imaging procedure. Furthermore, they are used to enhance contrast in images of the inside of the body obtained using X-rays, γ-rays, and radioactive particles.

Market Overview:

The latest research study on the global Medical Imaging Reagents market finds that the global Medical Imaging Reagents market reached a value of USD 12356.03 million in 2022. It’s expected that the market will achieve USD 17919.38 million by 2028, exhibiting a CAGR of 6.39% during the forecast period.

Strength

Development of economy and technology
Rise in disposable income
Rise in downstream demand

Weakness

Fierce competition in the industry
Industry integration
Economies of scale
High costs

Opportunity

Technology innovation
Emerging market
Great consuming power of the customers in the Europe and US

Threat

Supply chain disruption
Macroeconomic downturn
Rising labor costs
Fluctuations in the price of raw materials

Region Overview:

From 2023-2028, North America is estimated to witness robust growth prospects.

Company Overview:

GE Healthcare is one of the major players operating in the Medical Imaging Reagents market, holding a share of 25.69% in 2020.

GE Healthcare is a provider of transformational medical technologies and services. It specializes in medical imaging, information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, computerized data management, performance improvement, medical equipment and performance services.

Bracco is an international Group active in the healthcare sector through Bracco Imaging (diagnostic imaging), Acist Medical Systems (medical devices and advanced imaging agents injection systems), and the Centro Diagnostico Italiano diagnostic clinic in Milan.

Its subsidiary Bracco Imaging is one of the world’s leading companies in the diagnostic imaging field :X-Ray Imaging (including Computed Tomography-CT), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound, and Nuclear Medicine.

Segmentation Overview:

Among different product types, Contrast Media segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Diagnostics segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Medical Imaging Reagents market covered in Chapter 3:

Yangtze River Pharmaceutical
Thermo Fisher Scientific
Bracco Imaging
Beilu Pharmaceutical
Eli Lilly and Company
GE Healthcare
Jiangsu Hengrui Pharmaceuticals
Bayer Healthcare
Curium Pharma
Jubilant Pharma
Lantheus Medical Imaging
Guerbet

In Chapter 4 and Chapter 14.2, on the basis of types, the Medical Imaging Reagents market from 2018 to 2029 is primarily split into:

Nanoparticles
Fluorescent Dyes & Probes
Radiopharmaceuticals
Fluorescent Proteins
Quantum Dots
Contrast Media

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Medical Imaging Reagents market from 2018 to 2029 covers:

Diagnostics
Drug Discovery
Research and Development

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)